Recent Transactions

30-Jun-07
$52.0 billion
Canada flag
Target: 

BCE Inc.

U.S.A., Canada flags
Acquiror: 
Teacher's Private Capital, Providence Equity Partners Inc. and Madison Dearborn Partners, LLC

Advised the Board of BCE on a review of a range of strategic alternatives that culminated in an agreement to sell to a consortium consisting of Teacher's Private Capital, Providence Equity Partners and Madison Dearborn Partners for $52.0 billion that was ultimately terminated

12-Mar-09
$46.9 billion
United States flag
Target: 

Genentech, Inc.

Switzerland flag
Acquiror: 
Roche Holding Ltd.

Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company

27-Jul-15
$40.5 billion
Ireland flag
Target: 

Allergan Generics

Israel flag
Acquiror: 
Teva Pharmaceutical Industries Ltd.

Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business

14-Feb-11
$40.0 billion
Australia flag
Target: 

Australian National Broadband Network

Greenhill acted as sole adviser to the Australian government in connection with the National Broadband Network, which represents the single largest infrastructure project in the country’s history

18-Feb-14
$25.1 billion
United States flag
Target: 

Forest Laboratories Inc.

Ireland flag
Acquiror: 
Actavis plc

Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.

28-May-19
$25.0 billion
United States flag
Target: 

Total System Services, Inc. (TSYS)

United States flag
Acquiror: 
Global Payments Inc.

Advised Total System Services, Inc. (TSYS), a provider of payment processing, merchant services and related payment services, on its merger with Global Payments Inc., a payment technology company focused on merchant acquiring and software solutions

24-Mar-06
$21.2 billion
Germany flag
Target: 

Schering AG

Germany flag
Acquiror: 
Bayer AG

Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany

25-Apr-03
$20.8 billion
United States flag
Target: 

AMR Corporation

Advised AMR, parent of American Airlines, on strategic alternatives and implementation of a historic out-of-court restructuring through which a variety of stakeholder concessions were achieved, averting bankruptcy

09-Mar-09
$18.6 billion
United States flag
Target: 

Rohm & Haas Company

United States flag
Acquiror: 
The Dow Chemical Company

Advised The Dow Chemical Company during its negotiations pertaining to the Rohm & Haas settlement resolution

14-Apr-08
$17.7 billion+
United States flag
Target: 

Northwest Airlines

United States flag
Acquiror: 
Delta Air Lines

Advised Delta Air Lines in connection with its merger with Northwest Airlines (+Transaction value represents enterprise value of combined entity)

09-Aug-02
$17.6 billion
United States flag
Target: 

Adelphia Communications

United States flag
Acquiror: 
Time Warner Inc. and Comcast Corp.

Advised the Unsecured Creditors of Adelphia Communications representing $14.5 billion of value in Adelphia’s Chapter 11 proceedings. Advised on the sale of Adelphia’s assets to Time Warner and Comcast for $17.6 billion

26-Jan-15
$16.0 billion
United States flag
Target: 

MeadWestvaco Corporation

United States flag
Acquiror: 
Rock-Tenn Company

Provided fairness opinion to the Board of Directors of MeadWestvaco on the merger with RockTenn to create a powerful global provider of consumer and corrugated packaging solutions

27-Mar-18
$13.0 billion
Switzerland flag
Target: 

Novartis AG’s 36.5% stake in Consumer Health Joint Venture

United Kingdom flag
Acquiror: 
GlaxoSmithKline plc

Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture

15-Dec-10
$12.9 billion
U.S.A., Swiss flags
Target: 

Alcon, Inc.

Switzerland flag
Acquiror: 
Novartis AG

Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company

05-Feb-15
$10.5 billion
United States flag
Target: 

Wireline assets of Verizon Communications in California, Florida and Texas

United States flag
Acquiror: 
Frontier Communications

Advised the Board of Directors of Frontier in connection with its acquisition of wireline assets from Verizon in California, Florida and Texas

28-Mar-12
$10.4 billion+
United States flag
Target: 

Flow Control Business of Tyco International Ltd.

United States flag
Acquiror: 
Pentair, Inc.

Provided fairness opinion to the Board of Directors of Pentair, Inc. in connection with its all-stock merger with Tyco Flow Control, a division of Tyco International Ltd. (+Transaction value represents enterprise value of combined entity)

22-Feb-22
Pending
~$8.6 billion
United States flag
Target: 

TEGNA, Inc.

United States flag
Acquiror: 
Standard General

Advising TEGNA, a leading broadcasting and digital marketing services company, on its sale to Standard General, a hedge fund 

20-May-13
$8.5 billion
Ireland flag
Target: 

Warner Chilcott, plc

United States flag
Acquiror: 
Actavis, Inc.

Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc

03-May-07
$8.5 billion
U.S.A., Canada flags
Target: 

IPSCO Inc.

Sweden flag
Acquiror: 
SSAB Svenskt Stål AB

Acted as lead financial advisor to SSAB Svenskt Stål AB on its acquisition of IPSCO Inc., a leading Canadian producer of energy tubulars and steel plate in North America with an annual steel making capacity of 4.3 million tons

19-Feb-15
$8.4 billion
United Kingdom flag
Target: 

Rexam plc

United States flag
Acquiror: 
Ball Corporation

Advised Ball Corporation, a leading manufacturer of metal packaging products for the global beverage, food, personal care and household products industries as well as a provider of systems and technologies for the aerospace industry, on the acquisition of Rexam plc, a leading beverage can manufacturer

11-Oct-22
Pending
$7.9 billion
United States flag
Target: 

Westinghouse Electric Company

Canada flag
Acquiror: 
Brookfield Renewable Partners and Cameco

Advising the Independent Committee of Brookfield Renewable Partners, the flagship listed renewable power company of Brookfield Asset Management, in consortium with Cameco and other institutional partners, on the acquisition of Westinghouse Electric Company, one of the world’s largest nuclear services businesses, from Brookfield Business Partners

06-Nov-21
Pending
~$7.6 billion
France flag
Target: 

Equans

France flag
Acquiror: 
Bouygues Group

Advising Bouygues Group, a France-based leading diversified group active in construction, media and telecommunication, on the acquisition of Equans, a leading multi-technical services provider. Equans was created on 1 July 2021, as a separate division within Engie

20-Aug-12
$7.3 billion
United States flag
Target: 

Coventry Health Care Inc.

United States flag
Acquiror: 
Aetna

Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna

19-May-05
$7.2 billion+
United States flag
Target: 

US Airways Group

United States flag
Acquiror: 
America West Holdings

Advised America West Holdings in connection with its merger with US Airways Group. (+Transaction value represents enterprise value of combined entity, including capitalized operating leases of $4.8 billion)

12-Jun-08
$6.7 billion
United States flag
Target: 

Applied Biosystems Group

United States flag
Acquiror: 
Invitrogen Corporation

Provided fairness opinion to the Board of Directors of the Applera Corporation on the merger of its Applied Biosystems business, which serves the life science industry, with the Invitrogen Corporation, creating a global leader in biotechnology reagents and systems

Pages

show all